Lifeboat Foundation

We are living in a world that is global and exponential. Technology is taking things that used to be scarce and making them abundant—and these forces are reshaping the fields of medicine and healthcare in completely novel ways.

Opening this year’s Exponential Medicine conference in San Diego, Daniel Kraft, the curator of the conference, and faculty chair of Medicine and Neuroscience at Singularity University, took the audience on a whirlwind tour of the latest developments in healthcare and medicine.

Continue reading “‘It’s a Powerful Time to Reshape Healthcare Across the Planet’” »

https://defence.ru/article/dmitrii-rogozin-opublikoval-video…bilem-uaz/

Deep learning neural networks may work so well because they are tapping into some fundamental structure of the universe, research suggests.

Lung cancer treatment is moving beyond chemotherapy, with Merck & Co. setting the pace in a new category of therapies that harness the body’s immune system to fight tumors.

The U.S. drugmaker’s drug Keytruda reduced the risk of death or cancer progression by 50 percent, Merck said, unveiling details of a crucial study at a meeting of the European Society for Medical Oncology. The medicine gave patients an average of 10.3 months before their cancer progressed, compared with six months on chemotherapy. Unlike competitor Bristol-Myers Squibb Co., whose similar drug Opdivo failed in an advanced trial and caused its stock to plunge, Merck selected patients who harbored high levels of a protein thought to predict how well the immune-system drugs will work.

The results give Merck a head start — and not just on Bristol-Myers. Roche Holding AG and AstraZeneca Plc are also in the race for the best new immune therapy against lung tumors, the most common cancer in the world. Doctors will probably start testing patients soon after diagnosis to see whether they’re suited to treatment with Keytruda and can forgo the many side effects of chemotherapy, said Stefan Zimmermann, a chief oncologist at the Cantonal Hospital of Fribourg, Switzerland.

Continue reading “Merck Leads as Lung Cancer Treatment Moves Beyond Chemotherapy” »

People have been hunting down the legendary fountain of youth since antiquity. Does it exist? Could it ever, even theoretically, exist? A Russian scientist named Dr. Anatoli Brouchkov believes it’s out there, and he thinks he found it in 3.5-million-year-old bacteria. So what does Dr. Brouchkov do next? Inject himself with it, of course.

The bacteria, Bacillus F, was discovered in Siberia in 2009. The bacteria was at once impressive because, despite being roughly 3.5 million years old, it was alive in Siberian permafrost. Brouchkov believes there is a mechanism in this bacteria that allowed it to stay alive in the frost for millions of years. Hey, if bacteria can do it, so can we, right? Who knows, but Dr. Brouchkov was eager enough to experiment with that thought to inject himself with the stuff. Though it’s hard to say if the bacteria “worked” to make the scientist immortal, Dr. Brouchkov claimed in 2015 that he’s feeling better than ever. Only time will tell the rest of his story… Hear more about the unbelievable tale in the video below.

Has he found the fountain of youth?

Continue reading “A Russian Scientist Injected Himself With 3.5-Million-Year-Old Bacteria” »

California’s department of motor vehicles said late on Friday the most advanced self-driving cars will no longer be required to have a licensed driver, if federal officials deem them safe enough.

The regulator released a revision of draft regulations that opened a pathway for the public to access self-driving cars, prototypes of which automakers and tech companies are testing.

The redrafted regulations will be the subject of a public hearing on 19 October, in Sacramento.

Continue reading “Flipboard on Flipboard” »

https://youtube.com/watch?v=lJxV4kSWSUI

There has been a lot of talk recently about reusable rockets and asteroid mining making space travel cheaper, but a proposed idea for a maglev train into space might be the real answer.

Using existing maglev technology, the Startram project proposes to launch people and cargo down a 1,000-mile long tunnel 12 miles high at 20,000 mph using a superconducting cable.

Continue reading “A Train Into Space? Startram Project Could Make Colonizing Mars Easier” »

Paddy Neumann kind of looks like someone who’s really into brewing beer. But back when he was a third year student at the University of Sydney, the now Dr. Neumann started on a course of experimentation that would see him beat innovations by NASA’s top scientists.

For his final research project, Neumann was working with the university’s plasma discharge, mapping the electric and magnetic charges around it. He noticed the particles moving through the machine were going really fast. In fact, they were clocking in at around 14 miles per second.

“I looked at my numbers from that final year project and thought, You could probably make a rocket out of this,” he says. Particularly when you consider that conventional hydrogen-oxygen rockets only get around 2.8 miles per second.

Continue reading “How an Australian College Student Did What NASA Couldn’t” »

If you listen to the wrong people, the North American manufacturing industry is doomed.

There is no denying that the U.S. and Canada have been losing jobs to offshore competition for almost half a century. From 2000 to 2010 alone, 5.6 million jobs disappeared.

Interestingly, though, only 13 percent of those jobs were lost due to international trade. The vast remainder, 85 percent of job losses, stemmed from “productivity growth” — another way of saying machines replacing human workers.

Continue reading “Industrial robots will replace manufacturing jobs — and that’s a good thing” »